• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Protopanaxadiol

Protopanaxadiol

Product ID P6957
Cas No. 7755-01-3
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $114.20 In stock
5 mg $255.30 In stock
10 mg $428.70 In stock
25 mg $837.20 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Protopanaxadiol is a triterpene sapogenin originally found in species of Panax (ginseng) that exhibits anticancer, neuromodulatory, neuroprotective, and antioxidative activities. Protopanaxadiol prevents breakdown of vitamin D3 and acts as an antagonist at GABA-A receptors. Protopanaxadiol also inhibits proliferation of colorectal cancer cells and induces mitochondria- and caspase-dependent apoptosis in lung adenocarcinoma cells by decreasing the mitochondrial membrane potential and increasing release of cytochrome C, activation of caspases 3 and 9, and cleavage of PARP. In animal models of cerebral ischemia, protopanaxadiol increases activity of superoxide dismutase and Na+/K+ ATPases, stimulates expression of Bcl-2, and decreases infarct size and neurological deficits.

Product Info

Cas No.

7755-01-3

Purity

≥98%

Formula

C30H52O3

Formula Wt.

460.73

IUPAC Name

(3S,8R,9R,10R,12R,13R,14S, 17S)-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10, 14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16, 17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,12-diol

Appearance

White Powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

P6957 MSDS PDF

Info Sheet

P6957 Info Sheet PDF

References

Deb S, Chin MY, Adomat H, et al. Ginsenoside-mediated blockade of 1α,25-dihydroxyvitamin D3 inactivation in human liver and intestine in vitro. J Steroid Biochem Mol Biol. 2014 May;141:94-103. PMID: 24486455.

Xu H, Yu X, Qu S, et al. Protective effect of Panax quinquefolium 20(S)-protopanaxadiol saponins, isolated from Pana quinquefolium, on permanent focal cerebral ischemic injury in rats. Exp Ther Med. 2014 Jan;7(1):165-170. PMID: 24348784.

Zheng Y, Nan H, Hao M, et al. Antiproliferative effects of protopanaxadiol ginsenosides on human colorectal cancer cells. Biomed Rep. 2013 Jul;1(4):555-558. PMID: 24648985.

Zhang YL, Zhang R, Xu HL, et al. 20(S)-protopanaxadiol triggers mitochondrial-mediated apoptosis in human lung adenocarcinoma A549 cells via inhibiting the PI3K/Akt signaling pathway. Am J Chin Med. 2013;41(5):1137-52. PMID: 24117074.

Lee BH, Choi SH, Shin TJ, et al. Effects of Ginsenoside Metabolites on GABAA Receptor-Mediated Ion Currents. J Ginseng Res. 2012 Jan;36(1):55-60. PMID: 23717104.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • O9398

    Oxymetazoline Hydrochloride

    Imidazoline derivative; α1-adrenergic agonist,...

    ≥98%
  • O938582

    41-Oxo-rapamycin

    Impurity of rapamycin

    ≥95%
  • M1575

    7-Methyl-6-mercaptopurine

    Thiopurine antimetabolite; PRPP amidotransferas...

    ≥87%
  • K0552

    Kb NB 77-78

    CID-797718 analog; potential PKD1 binding agent...

    ≥98%
  • B8074

    3-tert-Butyl-5-Methoxy-1,2-quinone

    BHA derivative.

    ≥98%
  • E6397

    EPZ6438

    Potent and selective inhibitor

    ≥98%
  • I544766

    Intepirdine

    Selective 5-HT6 receptor antagonist

    ≥98%
  • D8276

    Dutasteride

    5-α-Reductase inhibitor.

    ≥99%
  • S7870

    Streptozocin

    Nitrosourea-amino sugar conjugate, DNA cross-li...

    ≥98%
  • D4873

    Meso-2,3-dimercaptosuccinic Acid

    Organosulfur, chelating agent.

    ≥98%
  • P2816

    S-(N-3-Phenylpropylthiocarbamoyl)-L-cysteine

    Cysteine-ITC conjugate.

    ≥98%
  • M0803

    MC1568

    HDAC inhibitor. May reduce blood pressure in hy...

    ≥98%
  • F5870

    N-formyl-Met-Leu-Phe

    Peptide, involved in neutrophil activation; FPR...

    ≥95%
  • D9752

    Dynasore

    Dynamin inhibitor.

    ≥98%
  • C9613

    Cyclosporin D

    Cyclosporin metabolite; weak calmodulin inhibit...

    ≥98%
  • F4680

    Flutamide

    Non-steroid; AR antagonist.

    ≥98%
  • L9602

    LY-2874455

    FGFR inhibitor.

    ≥98%
  • A2046

    Aflatoxin B2

    Mycotoxin produced by species of Aspergillus; D...

    ≥98%
  • C0148

    Calcitonin, human

    Endogenous neuropeptide hormone, lowers extrace...

    ≥95%
  • C4756

    Cloxacillin Sodium Monohydrate

    β-lactam; penicillin binding protein inhibitor...

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only